Pfizer announces positive topline results from Phase 3 study of hemophilia A gene therapy candidate
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
Laurus Labs has reported total income of Rs. 1,197.42 crores during the period ended June 30, 2024
Thyrocare Technologies has reported total income of Rs. 160.53 crores during the period ended June 30, 2024
Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024
Poly Medicure has reported total income of Rs. 401.69 crores during the period ended June 30, 2024
Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024
Vimta Labs has reported total income of Rs. 82.44 crores during the period ended June 30, 2024
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating patients living with Parkinson’s disease
These abstracts report on the company's three lead drug candidates, including olverembatinib
Subscribe To Our Newsletter & Stay Updated